Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 1,274

Document Document Title
WO/2018/005169A1
Devices and methods for vascular navigation, assessment and/or diagnosis are described which, determine the location of the tip of a vascular catheter using the introduction of a medium with a measurable parameter (e.g., temperature, lig...  
WO/2017/214956A1
Disclosed is a catheter device (10), comprising: a tubular structure (11); a plurality of fluid flow tube structures (13), each of which has a proximal direction (19) and a distal direction (18) and is disposed in a first axial direction...  
WO/2017/184728A1
An apparatus and method for using rotating shield brachytherapy (RSBT). In an aspect, the RSBT system and method can be used to maintain or increase tumor dose relative to conventional techniques with a dramatic reduction in radiation do...  
WO/2017/112891A1
Brachytherapy applicator systems and methods of use such as methods of introducing radiation to a target using the brachytherapy applicator systems. The systems may feature a cannula attached to a handle, wherein the cannula has a distal...  
WO/2017/075057A1
A method and system for treating a subject with a disorder which provides within the subject at least one photoactivatable drug for treatment of the subject, applies initiation energy from at least one source to generate inside the subje...  
WO/2016/196973A1
An exemplary system, method and computer-accessible medium for determining a location a radioactive seed(s) within a body, can include, for example receiving first imaging information of the radioactive seed(s) within the body based on a...  
WO/2016/179420A1
Various configurations of shielding materials within shielding layers, such as for use in shielding radiation from implanted radioactive carriers, are discussed herein.  
WO/2016/130572A3
Provided herein are methods of determining a subject's level of exposure to radiation and methods of determining a subject's risk of subsequent development of radiation disease or risk of poor prognosis from radiation exposure that inclu...  
WO/2016/109700A1
In various embodiments, an implantable drug-delivery device features one or more rigid drug reservoirs from which therapeutic agents are administered and which are refilled from a flexible reservoir within the device.  
WO/2016/070721A1
Provided in the present invention is a three-dimensional precise intracavitary radiotherapy method and system for treating tumours, comprising the steps of: (1) lesion three-dimensional quantitative measurement and analysis of three-dime...  
WO/2015/199784A3
The present invention generally relates to nanoscale wires and/or injectable devices. In some embodiments, the present invention is directed to electronic devices that can be injected or inserted into soft matter, such as biological tiss...  
WO/2015/183346A3
The present disclosure discloses methods and compositions for administering Cerenkov radiation-induced therapy (GRIT). In an aspect, the invention encompasses a composition comprising at least two radiation-sensitive molecules. In anothe...  
WO/2015/126526A1
A multi-dose disposable fluid delivery system includes at least one fluid container, a multi-use fluid path set, and a plurality of single-use fluid path sets. The at least one fluid container has a connection port configured for fluidly...  
WO/2015/061592A1
The present invention relates to liposomes useful for diagnosis and/or therapy of a target site, such as cancerous tissue. The compositions and methods disclosed herein find particular use in diagnosing and imaging cancerous tissue. The ...  
WO/2015/027149A1
Disclosed are methods and devices for monitoring total delivered dose of an analyte of interest, such as an iodine containing contrast media used during intravascular procedures. The device includes a flow rate measuring capability, and ...  
WO/2015/023307A1
A brachytherapy applicator including an elongated intracavitary applicator, a plurality of channels disposed within the elongated intracavitary applicator, at least one shielding element, and configured to receive at least one radioactiv...  
WO/2014/205076A1
Devices and techniques for permanent application of radioactive sources in the field of brachytherapy are described. In an embodiment, an implantable device for radiation therapy of pathological tissues directed toward the administration...  
WO/2014/189604A2
Brachytherapy seed insertion and fixation devices and systems to decrease implanted brachytherapy seed migration within tissue and minimize trauma. Component(s) with cavity or opening features are attached to a brachytherapy seed or seri...  
WO/2014/164460A1
Applicators for HDR brachytherapy for topical skin treatment which employ multiple channels for radioisotope sources, oriented by the applicator generally parallel to each other and to a desired treatment area skin surface. These applica...  
WO/2014/145397A1
The invention provides a medicament delivery vehicle, the vehicle comprising a RDC adapted to support the medicament on an outside surface of the carrier, an inside surface of the carrier, or homogeneously dispersed throughout the carrie...  
WO/2014/137980A1
Methods and systems for automatically and dynamically determining a dose of a radiopharmaceutical are disclosed. The dose may be determined based on, among other things, radiopharmaceutical information associated with at least one source...  
WO/2014/117001A1
This invention is in the field of labeled peptide construction for medical treatment and analysis. The invention relates to synthetic labeled peptide compositions, methods of synthesis, and methods of use for the synthetic labeled peptid...  
WO/2014/105971A1
The present invention provides a radiation-shielding container for a radiopharmaceutical that allows or a product fluid to be dispensed from a base component thereof.  
WO/2014/092804A1
The present invention relates to therapeutic immunoconjugates comprising SN-38 attached to an antibody or antigen-binding antibody fragment. The antibody may bind to EGP-1 (TROP-2), CEACAM5, CEACAM6, CD74, CD19, CD20, CD22, CSAp, HLA-DR,...  
WO/2014/085286A1
The present invention is a fragrance containing capsule composition dispersed into a lyotropic liquid crystalline surfactant phase as well as a consumer product base containing the same.  
WO/2014/074712A3
An ophthalmic radiation device having a substantially light-transparent wand configured to emit light propagating through the wand light from a series of illumination ports at least partially circumscribing a radioactive source disposed ...  
WO/2014/059667A1
The present invention relates to a design idea of a radioactive seed implanting template and a manufacturing method thereof. The manufacturing method comprises the following steps: (1) collecting image data about tumor portions of patien...  
WO/2014/043067A1
The present invention provides a device for displacing healthy or normal tissue away from radiation exposure during brachytherapy. In one embodiment, the device of the present invention comprises an inflatable component attached to the r...  
WO/2014/036627A1
Embodiments of the present invention provide for assessing the state of an 82Rb elution system. In certain embodiments, a system begins an assessment that comprises an elution, and a metric may be measured. This metric may be a concentra...  
WO/2014/036337A3
An applicator device is provided including a connecting unit. The connecting unit includes a first connector coupled to a first colpostat and a second connector coupled to a second colpostat. The first connector includes a first contact ...  
WO/2014/031950A1
This invention is a medicament delivery vehicle, the vehicle comprising tubular members adapted to removably receive the medicament and an expandable stent adapted to receive the tubular members. Also provided is a medicament delivery ve...  
WO/2014/021947A1
Systems and methods for rotating shield brachytherapy. In an aspect, some of the systems and methods can be used to facilitate shield selection for use in rotating shield brachytherapy. In an aspect, the invention is a shielded needle or...  
WO/2014/008594A1
A system and method for using ultrasound and a microbubble agent to induce ceramide accumulation in a target region including a population of cells associated with a tumor. An ultrasound system is directed to expose a target region in a ...  
WO/2013/134101A1
A fat reducing device and method utilizing optical emitters includes an array housing a plurality of optical emitters which are positioned to produce an optical output directed to a recipient, and a controller for instructing an operatio...  
WO/2013/049827A1
An apparatus for providing at least one treatment to at least one tissue having a first structural arrangement configured to expand a first portion at a distal end of the apparatus, a second structural arrangement configured to expand a ...  
WO/2013/033249A3
A device for irradiating cancer patients with neutrons, useful in Boron Neutron Capture Therapy, using at least one neutron emitter mounted and controlled so as to deliver a measured dose of neutrons directed at a treatment site or sites.  
WO/2013/029024A1
A brachytherapy device includes a bioabsorbable support and a plurality of microcapsules on the support. Each of the plurality of the microcapsules includes a plurality of microspheres and a bioabsorbable microcapsule wall that encloses ...  
WO/2013/022797A1
Compounds according to Formula I and Formula II are potent inhibitors of PSMA activity: The invention also provides pharmaceutical compositions of a complex of a radionuclide and a Formula I compound or a Formula II compound and methods ...  
WO/2013/019975A1
The invention provides compositions and methods to treat cancer with an agent that increases reactive oxygen species (ROS) levels in cancer cell mitochondria ("an XTPP agent") or a pharmaceutically acceptable salt thereof, an inhibitor o...  
WO/2013/006556A2
A shielding device includes two elongated, parallel tubes joined at a distal portion, and a shield at least one of removably and slidably situated at the distal portion. An assembly includes an applicator configured for a treatment site,...  
WO/2012/178173A1
Extracellular-targeted drug conjugates (EDC) in which a targeting moiety targeting a protein associated with the Na,K-ATPase is linked to a drug that interacts with the Na,K-ATPase through a linker a stable linker are useful in the treat...  
WO/2012/174557A1
Inhalable pharmaceutical compositions can include an aqueous dispersion of particles including a hydrophobic bioactive agent (e.g., CoQIO) suitable for continuous aerosolization. Due to their chemical composition and methods of manufactu...  
WO/2012/155124A3
It is an object of the present invention to provide improved pharmacological properties to molecules which bind to a target with low affinity (hereinafter referred to as a "ligand moiety") through linkage of such molecules to a metal bin...  
WO/2012/149417A1
A device and method for retaining a position of a treatment applicator are described. The device includes a perineal retainer body configured to receive the applicator, the perineal retainer body configured to form a positive stop with a...  
WO/2012/141387A1
The present invention relates to a device for manufacturing radiopharmaceuticals. The present device for manufacturing radiopharmaceuticals includes a first module unit which obtains synthetic products through a reaction caused by mixing...  
WO/2012/138749A1
The invention relates to charged or pro-charged cross-linking moieties and conjugates of cell binding agents and drugs comprising the charged or pro-charged cross-linking moieties and method of using the same to reduce ocular toxicity as...  
WO/2012/112699A2
Systems and methods for delivering and infusing formulations containing riboflavin or its analogues, or other ophthalmic formulations, into corneal tissue are disclosed. Systems and methods are further disclosed to cross-link the corneal...  
WO/2012/112317A1
A method of treating a tumor in a subject, or reducing or preventing metastasis of a tumor in a subject, is provided comprising administering to the subject an amount of a bacteria labelled with, or comprising, one or more radionuclides ...  
WO/2012/112699A3
Systems and methods for delivering and infusing formulations containing riboflavin or its analogues, or other ophthalmic formulations, into corneal tissue are disclosed. Systems and methods are further disclosed to cross-link the corneal...  
WO/2012/091757A1
Arginase enzyme inhibitors are disclosed for treating or diagnosing conditions characterized either by abnormally high arginase activity or abnormally low nitric oxide levels in a mammal, comprising administering compositions of the inve...  

Matches 1 - 50 out of 1,274